 |
Facts About Serevent |
Serevent (salmeterol) controls the symptoms of asthma and is considered a long-acting bronchodilator that GlaxoSmithKline has been producing with the FDA's approval in the United Stated States since 1994 (1990 in Europe). Serevent is used by itself and also as one of two ingredients in GlaxoSmithKline's asthma treatment Advair, the company's biggest product with sales of $4 billion a year. Asthma is an inflammatory disorder of the airways, characterized by periodic attacks of wheezing, shortness of breath, chest tightness, and coughing.
Consumer advocacy websites like WorstPills.org, Best Pills News listed the asthma drug salmeterol (SEREVENT) as a DO NOT USE drug after the Food and Drug Administration (FDA) announced on January 23, 2003 that a large safety study involving the drug had been halted prematurely because an interim analysis of outcomes suggested that the drug may be associated with an increased risk of life-threatening asthma episodes or asthma-related deaths.
Symptoms of asthma that would result in a Serevent prescription include:
- wheezing
- cough with or without sputum (phlegm) production
- shortness of breath that is aggravated by exercise
- breathing that requires increased work
- intercostal retractions (pulling of the skin between the ribs when breathing)
- extreme difficulty breathing
- bluish color to the lips and face
- severe anxiety
- rapid pulse
- sweating
- decreased level of consciousness (severe drowsiness or confusion) during an asthma attack
- nasal flaring
- chest pain
- tightness in the chest
- abnormal breathing pattern, in which exhalation (breathing out) takes more than twice as long as inspiration (breathing in)
- breathing which temporarily stops
- coughing up blood
Serious side-effects that may curtail the prescription of Serevent in the near future include:
- Death
- Serious Bronchial Damage
- Triggering of serious Asthma Attacks
If you or anyone you know has either taken or been prescribed Serevent for asthma or other related medical troubles, our expert lawyers are here to help you.
Contact our serevent lawyers now and obtain a case evaluation for free.
|
|
 |
Latest Serevent News |
|
| |
FDA Cannot Ignore Warnings on Crestor
house.gov, Jan 24, 2007
He also identified Crestor as one of five drugs on the market that he believed posed serious safety concerns that should have been further investigated....
Read more >
FDA Approves First Generic Pravastatin
fda.gov, Dec 27, 2006
Pravastatin is indicated for the treatment of individuals with high cholesterol levels (hyperlipidemia) or who are at increased risk for atherosclerosis-related...
Read more >
Statin Users Risk Heart Attacks By Stopping Treatment
healthfinder.gov, Dec 11, 2006
People with high cholesterol levels who stop taking the drugs called statins increase their risk of heart attacks by at least 30 percent, a Dutch study finds....
Read more >
Some Drugs From Canadian Web Sites Fake: FDA
healthfinder.gov, Nov 27, 2006
A number of prescription drugs ordered from 10 Web sites linked to a Canadian pharmacy were fake, according to tests by the U.S. Food and Drug Administration....
Read more >
Elderly Patients Discontinue Use Of Cholesterol-Lowering Drugs
ahrq.gov, Nov 13, 2006
The researchers studied statin use among 34,501 elderly patients enrolled in the New Jersey Medicaid ...
Read more >
Hispanics Benefit From Cholesterol-Lowering Statins Like Crestor
healthfinder.gov, Oct 19, 2006
CRP is a marker of inflammation, and high levels of CRP correlate with increased risk of coronary heart disease....
Read more >
Alert For Healthcare Professionals Regarding Crestor
fda.gov, Oct 05, 2006
Some individuals taking Crestor will experience muscle side effects, most commonly mild aches and very rarely severe muscle damage...
Read more >
Fake Crestor Sold On Canadian Web Sites
womenshealth.gov, Sep 21, 2006
Even though the drugs seized by the FDA were ordered from Canada-based Mediplan, the drugs were not shipped from Canada, the AP reported...
Read more >
Aggressive Statin Therapy May Reverse Atherosclerosis
womenshealth.gov, Aug 10, 2006
Intensive cholesterol-lowering therapy using Crestor not only reduced LDL or bad cholesterol levels but actually reversed atherosclerosis...
Read more >
Abbott and AstraZeneca to Develop Crestor and TriCor Combo
Press Release, Jul 27, 2006
Abbott and AstraZeneca announced today a collaboration to co-develop and market a combination treatment that will target all three important blood lipids ...
Read more >
FDA Alert On Rosuvastatin Calcium, Marketed As Crestor
Enter Source, Jun 22, 2006
...
Read more >
This Five Year Crestor Study Will Evaluate The Drug
4woman.gov, May 24, 2006
You must be taking Crestor and be a male over age 50 or a female over age 60...
Read more >
FDA Crestor Alert
fda.gov, Apr 27, 2006
Asian patients compared with a Caucasian control group that found drug levels to be elevated approximately ...
Read more >
Crestor Dosage
fda.gov, Mar 17, 2006
The 40mg dose of CRESTOR is reserved only for those patients who have not achieved their LDL C goal utilizing ...
Read more >
Crestor Warning On Pregnancy And Lactation
www.fda.gov, Mar 01, 2006
Rosuvastatin should be administered to women of childbearing age only when such patients are highly unlikely to conceive and have been informed of the potential hazards...
Read more >
FDA Updated Safety Information For Crestor
accessdata.fda.gov, Feb 15, 2006
In treating Asian Americans, since a large pharmacokinetic study found that this group of patients had drug levels about twice as high as a Caucasian control group...
Read more >
Renal Week Debates On Drugs And The Kidney Damage Symptoms
Press Release, Jan 31, 2006
Public Citizen, a public interest organization headquartered in Washington, DC, petitioned the FDA to remove Crestor from the market...
Read more >
Crestor Drug Warning
energycommerce.house.gov, Jan 16, 2006
are the signals for the potential progression to renal failure in a small number of patients, this may represent an unacceptable risk since currently approved statins do ...
Read more >
FDA Alert On Crestor
FDA.Gov, Jan 02, 2006
Crestor is being revised to highlight important information on the safe use of Crestor to reduce the risk for serious muscle toxicity ...
Read more >
Center For Drug Evaluation On Crestor Medication
FDA.gov, Dec 01, 2005
FDA is also making statements about the muscle and kidney safety of Crestor ...
Read more >
FDA News Information Concerning Crestor
fda.gov, Nov 22, 2005
FDA is providing up-to-date information about the risk of serious muscle damage in patients ...
Read more >
Cholesterol Drug Crestor Produces More Side Effects
healthfinder.gov, Nov 14, 2005
The FDA denied the group's request, but required the drug to carry a revised warning label to emphasize the risk of muscle damage...
Read more >
FDA Public Health Advisory on Crestor
fda.gov, Oct 17, 2005
Ongoing controlled clinical trials of Crestor and other statins, epidemiologic studies....
Read more >
Updated Patient and Healthcare Provider Information Concerning Crestor
fda.gov, Sep 09, 2005
Agency Effort to Provide Public with Early Access to Emerging Safety Information ...
Read more >
Crestor Has A Much Lower Rate
healthfinder.gov, Aug 16, 2005
Crestor Has A Much Lower Rate Of Adverse Side Effects Than Baycol...
Read more >
Synthetic Lipid-Lowering Agent
accessdata.fda.gov, Aug 09, 2005
Rosuvastatin is an inhibitor of 3-hydroxy-3-methylglutaryl-coenzyme A (HMG-CoA) reductase...
Read more >
Reported In Patients Taking Crestor As Well As Other Statin Drugs
fda.gov, Aug 05, 2005
Rhabdomyolysis (serious muscle damage) has been reported in patients taking Crestor as well as other statin drugs....
Read more >
Crestor Is A Drug That Comes Under The Umbrella
ryar.org, Jul 13, 2005
Crestor Is A Drug That Comes Under The Umbrella Of ‘Statins’ And Is Prescribed For Cholesterol Reduction...
Read more >
Unfortunately Create Unnecessary Alarm
fda.gov, Jun 23, 2005
CRESTOR Are Misleading, And Unfortunately Create Unnecessary Alarm For Patients Who Need This Medication...
Read more >
Crestor A Member Of A Class Of Cholesterol Lowering Drugs
FDA, May 20, 2005
Crestor, a member of a class of cholesterol-lowering drugs commonly referred to as “statins”, was approved in the U.S....
Read more >
Rosuvastatin Calcium Marketed as Crestor Information
FDA, May 13, 2005
Rosuvastatin Calcium Marketed as Crestor Information...
Read more >
FDA Provides Updated Patient and Healthcare Provider Information Concerning Crestor
FDA, May 05, 2005
FDA Provides Updated Patient and Healthcare Provider Information Concerning Crestor...
Read more >
FDA Provides Updated Patient and Healthcare Provider Information Concerning Crestor
FDA, Apr 27, 2005
Part of an Ongoing Agency Effort to Provide Public with Early Access to Emerging Safety Information In order to provide Americans with earlier access ...
Read more >
Medtronic Announces Additional Devices Affected in Voluntary Recall of Certain Monophasic LifePak 500 Automated External Defibrillators
FDA, Apr 25, 2005
Medtronic Announces Additional Devices Affected in Voluntary Recall of Certain Monophasic LifePak 500 Automated External Defibrillators...
Read more >
FDA Rejects Public Citizen's Petition for AstraZeneca's CRESTOR(R)
biz.yahoo, Mar 30, 2005
U.S. Food and Drug Administration (FDA) has formally denied Public Citizen's Health Research Group's (HRG) petition to remove CRESTOR...
Read more >
Citizen's Health Research Group's (HRG) Petition To Remove CRESTOR(R) (Rosuvastatin Calcium) From The Market
fda, Mar 16, 2005
The U.S. (FDA) Has Formally Denied Public Citizen's Health Research Group's (HRG) Petition To Remove CRESTOR(R) (Rosuvastatin Calcium) From The Market...
Read more >
The Crestor“Warnings” And “Dosage And Administration” Sections Of The Label Have Been Revised To More Strongly
fda gov, Mar 15, 2005
The Crestor“Warnings” And “Dosage And Administration” Sections Of The Label Have Been Revised To More Strongly Emphasize The Risks Of Myopathy, Particularly At The Highes...
Read more >
Mercy Hospital Foundation Receives $50,000 Donation Through the CRESTOR(R) Charity Challenge at PGA TOUR's
all mericanpatriots, Mar 08, 2005
For Phil Mickelson's performance, CRESTOR, an AstraZeneca pharmaceutical product, and the Ford Championship at Doral, will donate $50,000 to the Mercy Hospital Foundation...
Read more >
FDA issues Health Advisory on Crestor
FDA, Mar 02, 2005
Astra-Zeneca Pharmaceuticals today released a revised package insert for Crestor ...
Read more >
FDA Admonishes Crestor Manufacturer Over Ads
Press release, Feb 14, 2005
FDA Sends AstraZeneca Letter Regarding Crestor Advertisements...
Read more >
Crestor (rosuvastatin): New Warning Label
Federal Gov Article, Feb 04, 2005
Crestor Announces New Method Of Warning Consumers...
Read more >
FDA Public Health Advisory for Crestor (rosuvastatin)
FDA Article, Jan 27, 2005
Astra-Zeneca Pharmaceuticals today released a revised package insert for Crestor (rosuvastatin) for use in the 22 member states of the European Union (EU). ...
Read more >
VA Study on Cholesterol Drug May Protect Vision
Veterans Health Administration, Nov 24, 2004
Elderly men who take cholesterol-lowering drugs known as statins are less likely to develop age-related macular degeneration...
Read more >
Cholesterol-Lowering Statins May Protect Against Colorectal Cancer
nci.nih.gov, Nov 24, 2004
Drugs taken by millions of Americans to lower cholesterol may also reduce the risk of colorectal cancer, a new study suggests....
Read more >
Keeping Cholesterol Under Control
fda.gov, Nov 23, 2004
The body needs cholesterol for digesting dietary fats, making hormones, building cell walls, and other important processes. ...
Read more >
Fatty cholesterol deposits raising the risk of heart disease.
fda.gov, Nov 23, 2004
One of the main ways blood cholesterol can reach undesirable levels is through a diet high in saturated fat and cholesterol. ...
Read more >
Public Citizen's Petition to Remove Crestor From the Market
Public Citizen, Oct 29, 2004
Petition Letter to the FDA from the Public Citizen Health Research Director, Sidney M. Wolfe, MD to remove Crestor from the market....
Read more >
Patients in the Dark About Cholesterol Drug Recall
Public Citizen, Oct 31, 2002
FDA Needs Statutory Authority to Order and Enforce Recalls; Drug Industry Should Pay for Patient Notification, Consumer Advocate Says...
Read more >
Milwaukee Golf Charities Receives $50,000 Donation
Enter Source, Jan 01, 1900
Milwaukee Golf Charities Receives $50,000 Donation Through The CRESTOR(R) Charity Challenge At PGA Tour's...
Read more >
More Serevent-Related News>
|
|
|
 |
Regional Resources |
|
| |
Search for Serevent-related resources in your State:
|
|
| |
|
|
|
| |
|
|
|
|
|
| |
Did You Know? |
|
| |
Consumer advocacy websites like WorstPills.org, Best Pills News listed the asthma drug salmeterol (SEREVENT) as a DO NOT USE drug after the Food and Drug Administration (FDA) announced on January 23, 2003 that a large safety study involving the drug had been halted prematurely because an interim analysis of outcomes suggested that the drug may be associated with an increased risk of life-threatening asthma episodes or asthma-related deaths.
|
|
|
| |
|
